1. A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn's Disease Refractory to Biologic Therapy 
Geoffrey M. Forbes, Marian J. Sturm, Rupert W. Leong, Miles P. Sparrow, Dev Segarajasingam, Adrian G. Cummins, Michael Phillips, Richard P. Herrmann 
Clinical Gastroenterology and Hepatology 
Volume 12, Issue 1, Pages (January 2014)
DOI: /j.cgh
Copyright © 2014 AGA Institute Terms and Conditions

2. Figure 1
Study overview.
Clinical Gastroenterology and Hepatology  , 64-71DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

3. Figure 2
CDAI score of 15 subjects at study entry and at day 42. Broken lines indicate patients without clinical response.
Clinical Gastroenterology and Hepatology  , 64-71DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

4. Figure 3
Mean CDAI by study visit (n = 15). Restricted cubic spline mean regression line with 95% confidence intervals (shaded area). Data points for all patients are shown.
Clinical Gastroenterology and Hepatology  , 64-71DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions